MedPath

Cognitive Behavioral Therapy (CBT)-Insomnia for Lung Cancer

Not Applicable
Completed
Conditions
Chronic Insomnia
Registration Number
NCT02121652
Lead Sponsor
State University of New York at Buffalo
Brief Summary

The purpose of this study is to determine whether cognitive behavioral therapy (CBT) is effective for insomnia in lung cancer survivors.

Detailed Description

A randomized controlled clinical trial will be used to test the efficacy of this brief CBT-I compared to attention control on sleep, mood, functional status and quality of life in lung cancer survivors and evaluate the feasibility of translating an evidence-based CBT-I into the clinical setting.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • 6 weeks from surgery for stage 1 or 2 Non Small Cell Lung Cancer
  • chronic insomnia
Exclusion Criteria
  • Other preexisting sleep disorders
  • Unstable medical illnesses

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Sleep Efficiency5 weeks

Sleep Efficiency \> 85% measured with a seven-day sleep diary. The score is calculated based on participants' recording of time asleep (minutes) divided by time in bed (minutes).

Sleep Efficiency greater than or equal to 85% indicates good sleep quality, and values less than 85% indicate poor sleep quality.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

SUNY University at Buffalo

🇺🇸

Buffalo, New York, United States

Roswell Park Cancer Institute Thoracic Clinic

🇺🇸

Buffalo, New York, United States

SUNY University at Buffalo
🇺🇸Buffalo, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.